Physician profile
David S Weisman
NPI 1235302803
$122,057.25
in general payments reported to CMS, 2019-2025
21 companies · $75K in 2025
The $75K reported for 2025 was more than what 97% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,183 · 2020: $283 · 2021: $1,204 · 2022: $2,112 · 2023: $6,333 · 2024: $36K · 2025: $75K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $106K · Food and Beverage: $8,334 · Travel and Lodging: $3,192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $105,750.00 |
| Food and Beverage | $8,333.62 |
| Travel and Lodging | $3,191.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $78,158.27 | 2019-2025 | Carto 3, Nuvision Ice Catheter, Octaray Mapping Catheter |
| Medical Device Business Services, INC. | $35,250.00 | 2023-2024 | Carto 3 |
| Abbott Laboratories | $3,992.29 | 2019-2025 | Aveir, Amplatzer Amulet, Viewmate |
| Boston Scientific Corporation | $1,494.49 | 2021-2025 | Watchman Flx, Watchman, Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $908.29 | 2021-2025 | Azure Xt Dr Mri Surescan, Micra, Linq II |
| Medtronic Vascular, INC. | $513.55 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $232.10 | 2019-2023 | Xarelto |
| Abiomed | $217.38 | 2021 | |
| Pfizer INC. | $203.81 | 2019-2023 | |
| Atricure, INC. | $190.48 | 2022-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Philips North America LLC | $160.67 | 2021-2023 | |
| Volta Medical INC | $128.38 | 2024 | Vx1 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $126.08 | 2021-2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $118.06 | 2021-2025 | Eliquis |
| Impulse Dynamics (USA) INC. | $104.66 | 2022-2024 | Optimizer, Optimizer |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $93.57 | 2021-2023 | |
| Cardiva Medical, INC. | $81.92 | 2021-2022 | |
| Kestra Medical Technology Services, INC. | $42.02 | 2022 | |
| Novartis Pharmaceuticals Corporation | $23.95 | 2025 | |
| Amgen INC. | $17.28 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Weisman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.